Skip to content
healthcare.dev

TOUJEO

NDC 0024-5869, insulin glargine, injection, solution, from Sanofi-Aventis U.S. LLC.

Product NDC
0024-5869
Status
Listed
Labeler
Sanofi-Aventis U.S. LLC
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA206538
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0024-5869 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INSULIN GLARGINE300 U/mL

Pharmacologic classes

Insulin Analog [EPC]; Insulin [CS]

Package NDCNDC-11Package
0024-5869-00000245869001 SYRINGE in 1 CARTON (0024-5869-00) / 1.5 mL in 1 SYRINGE
0024-5869-03000245869033 SYRINGE in 1 CARTON (0024-5869-03) / 1.5 mL in 1 SYRINGE (0024-5869-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c9561d96-124d-48ca-982f-0aa1575bff36
  • NADAC price for package 00024586903

    GET /v1/drugs/nadac/00024586903

Use it

Look up 0024-5869 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0024-5869 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0024-5869. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.